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Zika virus (ZIKV), an emerging mosquito-borne fla-
vivirus, causes a mild dengue fever-like illness but 
has recently been associated with neurological dis-
ease and severe birth defects. The virus is currently 
causing a large epidemic in the Americas. Here, we 
report a male-to-female sexual transmission of ZIKV 
in Germany in April 2016, following travel to Puerto 
Rico of the male patient, demonstrated by subsequent 
seroconversions and molecular identification of identi-
cal virus sequences from both patients.
Case descriptions
On 13 April 2016, the index patient, a 35-year old male 
German citizen, presented at his general practitioner 
with signs and symptoms of a common cold. He had 
returned to northern Germany on 5 April after a one-
week stay in Puerto Rico. At the time, a Zika virus 
(ZIKV) outbreak was ongoing in Puerto Rico [1]. On 6 
April, the patient felt weak, but attributed his symp-
toms to travel-associated exhaustion. One day later, 
he noticed swollen nuchal lymph nodes. From 8 to 10 
April his joints (fingers, knees and ankles) were swol-
len and painful, such that he could barely walk, and 
he had a hardly visible but very itchy rash. Neither 
conjunctivitis nor fever were present. After cessation 
of these symptoms, the patient developed symptoms 
of an upper respiratory tract infection lasting for about 
one week, dominated by a runny nose and persistent 
sinus headaches. A serum sample of 13 April was nega-
tive for Dengue virus (DENV) NS1 antigen, but showed 
an ZIKV antibody IgM titre of 1:1,280 and an IgG titre 
of 1:20,480 by indirect immunofluorescence test (IIFT, 
reference: < 1:20) [2]. Results were also positive for 
anti-ZIKV IgM and IgG in a commercial ELISA (Anti-
Zika Virus ELISA, EUROIMMUN, Lübeck, Germany) [2]. 
Consequently, Zika virus disease (ZVD) was diagnosed 
(Figure 1).
On 17 April, his 29-year-old female partner who had not 
been travelling, also developed upper respiratory tract 
infection. On 20 April, she additionally noted swollen 
lymph nodes in the neck. The following morning she 
noticed having unusually red cheeks and a non-itchy 
rash which spread within one to two hours to her entire 
body, except the palms of her hands. Fever and con-
junctivitis were not noted. On the same day, 21 April, 
the index patient was informed about his ZIKV infec-
tion and his partner was tested for ZIKV infection, too. 
She was negative for anti-ZIKV IgG and IgM in IIFT and 
ELISA, as well as DENV NS1-Antigen, however, ZIKV RNA 
was detected in serum and urine by real time RT-PCR 
(RealStar Zika Virus RT-PCR Kit 1.0, altona Diagnostics, 
Hamburg, Germany) and she was diagnosed with ZVD 
(Figure 1). ZIKV RNA was not detected in saliva. During 
the next days she developed swollen and painful joints 
affecting some fingers and the ankles. Symptoms 
resolved by 25 April.
The male patient had ZIKV RNA in urine, but not in 
saliva and serum 13 days after onset of symptoms. One 
semen sample taken 45 days after onset of symptoms 
tested positive for ZIKV RNA and the RNA load was 
6x104 copies/mL. In contrast, urine and serum sam-
ples were then both negative for ZIKV RNA. ZIKV could 
not be isolated in cell culture from semen. The female 
patient tested positive for anti-ZIKV-IgM and IgG in the 
IIFT and ELISA 34 days after onset of symptoms dem-
onstrating ZIKV seroconversion. Her urine and serum 
samples then tested negative for ZIKV RNA.
Sequence analysis from urine samples
A fragment of the ZIKV NS5 gene (ca 400 bp, exclud-
ing primers) could be amplified from the urine of both 
patients (GenBank accession numbers KX253994 and 
KX253995). Sequence analysis showed 100% identity 
of the samples from both patients (exhibiting only one 
2 www.eurosurveillance.org
synonymous substitution in comparison to the closely 
related ZIKV strains from GenBank). Based on the phy-
logeny the two sequences clustered together with the 
recently detected ZIKV strains from Puerto Rico and 
other Central and South American countries into the 
same ZIKV outbreak clade from the Asian ZIKV lineage 
(Figure 2).
The female patient did not recall any mosquito bites 
during the previous few weeks, when it was spring. In 
addition, ZIKV vector mosquito species Aedes aegypti 
or Ae. albopictus have not been described anywhere 
in northern Germany, thus a mosquito-borne transmis-
sion was regarded as highly unlikely. She had last been 
in an area at risk for ZIKV infection between Christmas 
2015 and mid-January 2016, when the couple had vis-
ited a later ZIKV-affected country together. A male-to-
female sexual ZIKV transmission was assumed given 
the sequence of clinical symptoms in the two patients 
and subsequent demonstration of seroconversion in 
the female patient. The molecular analyses and pro-
longed detection of ZIKV RNA in semen support the 
assumption. The couple reported multiple sexual con-
tacts (vaginal intercourse without condoms) from the 
day of his return from travel (5 April) to onset of her 
rash (21 April), i.e. slightly before and up to 12 days 
after his onset of ZVD-like symptoms (Figure 1). She is 
taking oral contraceptives and was not pregnant at the 
time of infection. He did not report haematospermia or 
symptoms of prostatitis.
Background
ZIKV is an emerging mosquito-borne flavivirus that 
causes a mild, dengue fever-like illness termed ZVD 
[3]. The most common symptoms are rash, arthralgia, 
and conjunctivitis. ZIKV infection has recently been 
associated with neurological disease and severe birth 
defects [4-6]. The Asian genotype of ZIKV is currently 
causing a large epidemic in the Americas [7]. ZIKV 
infection has also been detected in returning travellers 
from endemic and epidemic regions [8,9]. The virus is 
most likely transmitted through bites of infected Ae. 
aegypti and Ae. albopictus mosquitoes [10,11]. Sexual 
transmission, which had first been assumed in 2008 
in the United States (US) in the wife of a man who had 
previously been to Senegal [12]. Circumstantial evi-
dence suggested possible sexual transmission by vagi-
nal intercourse in the days after the return of the male 
patient and before onset of symptoms of ZIKV infec-
tion and concomitant prostatitis. He had developed 
haematospermia four days after disease onset. Further 
potential evidence for sexual transmissibility was seen 
in 2013 by detection of ZIKV RNA in semen (2.9x107 and 
1.1x107 copies/mL) and urine of a patient from Tahiti 
with haematospermia some weeks after symptoms 
compatible with ZVD. ZIKV was successfully cultured 
from semen and urine [13]. Additional evidence was 
reported from the United Kingdom by detection of ZIKV 
RNA from semen 27 and 62 days after onset of febrile 
illness in a man who had returned from the Cook 
Islands in 2014, and a prolonged potential for sexual 
transmission was discussed [14]. A male-to-male sex-
ual transmission after anal sex was reported from the 
US in January 2016, after travel to Venezuela of the 
index patient, as shown by positive anti-ZIKV IgM and 
IgG detection in both patients. Haematospermia and 
symptoms of prostatitis were absent [15]. Retrospective 
analyses showing serological evidence of ZIKV infec-
tion suggested sexual transmission in an Italian cou-
ple after return of the male partner from Thailand [16]. 
A case series with incomplete results has been pub-
lished from the US [17], describing infections in women 
Figure 1
Sequence of events in sexually transmitted Zika virus infection from male traveller returning from Puerto Rico, to his 
female partner, Germany, April 2016
Arrival in Germany      Weakness
Swollen lymph nodes around neck
Itchy rash, joint pain
Male Day Day Day Day Day Day Day Day
case -3 -2 -1 0 5 12 13 45
ZIKV IgM+, IgG+, Serum PCR- Urine PCR+, saliva PCR- Semen PCR+, serum PCR-, urine PCR-, 
ZIKV IgM+, IgG+
 - - - - - - - - - - - - - Multiple sexual contacts between patients - - - - - - - - - - - - - -
Serum PCR+, urine PCR+, saliva PCR-, ZIKV IgM-, IgG- Serum PCR-, urine PCR-, ZIKV IgM+, IgG+
Female Day Symptoms of Day Day
case -16 a cold 0 34
Rash, joint pains
Swollen lymph nodes around neck




ZVD Symptoms of a coldsince 28 March
Stay in Puerto Rico 
Physician consultation
ZIKV: Zika virus; ZVD: Zika virus disease.
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following sexual contacts with their male partners 
after these had travelled in Central America and the 
Caribbean. Recently, sexual transmission was shown 
in a French woman after unprotected vaginal and oral 
intercourse with her male partner who had previously 
travelled to Brazil. ZIKV was detected by PCR and cul-
ture in his urine and semen on days 18 and 24 (2.9x108 
and 3.5 x107 copies/mL in semen) following a period of 
symptomatic ZIKV infection. He did not report haema-
tospermia [18]. A roughly 100,000 times higher ZIKV 
load in semen (8.6x1010 copies/mL) than in blood was 
recently demonstrated in a traveller returning to France 
from Brazil and French Guyana [19].
Conclusions
Here we describe a sexually transmitted ZIKV infec-
tion in Germany. The ZIKV RNA load in semen on day 
45 post symptom onset was significantly lower than in 
previous reports [13,18,19]. Sexual transmission of ZIKV 
is of special concern during pregnancy and specific 
guidelines for prevention have been published [4,20]. 
In order to protect the fetus, the European Centre for 
Disease Prevention and Control (ECDC) notes that male 
travellers returning from affected areas should con-
sider using a condom with a pregnant partner until 
the end of pregnancy [4]. In addition, the World Health 
Organization (WHO) now advises male travellers 
returning from areas with ongoing ZIKV transmission 
Figure 2
Maximum likelihood phylogenetic tree, sexually transmitted Zika virus infection from male traveller returning from Puerto 





























































In the entries in red, P represent the two patients described here.
The tree is based on nt sequences of the partial NS5 gene (ca 380 bp). It shows the placement of the ZIKV virus strains that were characterised 
directly from the urine (obtained from both patients, P1 and P2) in comparison to all available Zika virus (ZIKV) sequences in GenBank. 
The analysis was performed under the best fit nt substitution model identified as the Tamura-Nei (TN93 + Γ) model using jModelTest v2. 
To assess the robustness of each node, a bootstrap resampling process was performed (1,000 replicates) using the nearest neighbour 
interchange (NNI) branch-swapping method available in PhyML v3.0. For better visualisation of the position of the ZIKV strains identified 
in both patients we magnified the area of the American ZIKV outbreak clade which indicates the location of ZIKV from this study (red). The 
taxon information includes the GenBank accession number, isolation/detection year and country where the virus was isolated/detected. 
Scale bar indicates mean number of nt substitutions per site.
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to practice safer sex or consider abstinence for at 
least eight weeks after their return in order to reduce 
the potential risk of onward sexual transmission. This 
period extends to at least six months if symptoms of 
ZIKV infection occur, during or after travel [20]. In con-
trast to previously described index cases involved in 
sexual transmission, our case did not notice haemato-
spermia. It will be important to elucidate if haemato-
spermia is associated with a higher ZIKV load in semen 
and if there is a correlation with the risk of sexual 
transmission of ZIKV. In addition, experimental data on 
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